Katy Mercer

Lymphoma Senior Trial Manager 🧬 Clinical Researcher 🔬 Proud member of team SCTU 💊

[Southampton CTU @SouthamptonCTU]

The REMoDL-A trial is now open!! Researchers are looking at whether adding a targeted #cancer drug called acalabrutinib to standard chemotherapy could improve outcomes for patients with DLBCL, an aggressive form of non-Hodgkin #lymphoma. Find out more https://t.co/5I0bgLkPvs

[Southampton CTU @SouthamptonCTU]

Long-term results of the IELSG-32 trial were presented at #EHA2021 today. 70% of patients with #lymphoma of the brain or spinal cord who had chemoimmunotherapy (MATRix) followed by a stem cell transplant were alive after seven years. Read the abstract https://t.co/QA9WR6SEGy

[Katy Mercer @KatyMercer15]

@SianHighviewAcu @SouthamptonCTU @UKCTUNetwork Thank you Sian, really appreciate your support 😃

[Southampton CTU @SouthamptonCTU]

Happy #InternationalClinicalTrialsDay! Katy is a Senior Trial Manager overseeing several trials to improve the treatment of #lymphoma. Read more in our #ICTD2021 blog – https://t.co/SPOwyGtCbT #CTD2021 @UKCTUNetwork

[Richard Evans @RichardJaEvans]

A really sad day for everyone here at @bloodcancer_uk

[Ben Goldacre @bengoldacre]

OUR NEW PAPER.

Factors associated with COVID-19-related hospital death in the linked electronic health records of 17 MILLION adult NHS patients.

Largest study of its kind ever, anywhere.

The power of UK / NHS data, realised.

https://t.co/XeQj4IG8I8

https://t.co/SpglPKpJSk

[Dorset Police @dorsetpolice]

We lit up @RBCH_NHS in blue this evening at 8pm when local officers and staff not deployed on an operational incident showed our support for our NHS, key workers and community care professionals. 💙 👮 👏

#StayHomeSaveLives
#ClapForTheNHS
#COVID19